Polycystic ovary syndrome - Metformin treatment in pregnancy
Abstract
IV.The history of polycystic ovary syndrome V. Polycystic ovaries a. Definition b.Prevalence VI.Polycystic ovary syndrome a. Definition b.Prevalence VII.Pathogenesis a. Genetic predisposition b.Prenatal factors c.Environmental factors d.Insulin resistance e. Anthropologic reflections VIII.Clinical presentations of PCOS a. Menstrual disturbances b.Obesity c. Hirsutism d.Androgenic alopecia e. Acantosis nigricans IX.PCO, PCOS and early pregnancy complications a. PCO and early pregnancy loss b.PCOS and early pregnancy loss 1. Hypersecretion of LH 2. Hyperandrogenism 3. Insulin resistance X. PCOS and pregnancy complications in the second and third trimester a. PCO, PCOS and gestational diabetes mellitus b.PCOS and pre-eclampsia
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.